These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24306088)

  • 61. A 5-year follow-up to evaluate the efficacy and safety of ofatumumab added to fludarabine and cyclophosphamide in patients with relapsed chronic lymphocytic leukemia: final analysis of the COMPLEMENT 2 trial.
    Grosicki S; Lech-Maranda E; Govind Babu K; Rybka J; Litvinskaya E; Loscertales J; Kriachok I; Kłoczko J; Rekhtman G; Homenda W; Blonski J; Stefanelli T; Vincent G; Banerjee H; Robak T
    Leuk Lymphoma; 2020 Jul; 61(7):1748-1751. PubMed ID: 32107948
    [No Abstract]   [Full Text] [Related]  

  • 62. Obstructive sleep apnea secondary to chronic lymphocytic leukemia.
    Chehal A; Haidar JH; Jabbour R; Yammout B; Bazarbachi A
    Ann Oncol; 2002 Nov; 13(11):1833. PubMed ID: 12419760
    [No Abstract]   [Full Text] [Related]  

  • 63. Efficacy and safety of oral fludarabine/cyclophosphamide regimen in previously treated indolent lymphomas.
    Stefoni V; Alinari L; Musuraca G; Tani M; Marchi E; Gabriele A; Fina M; Pileri S; Baccarani M; Zinzani PL
    Leuk Lymphoma; 2005 Dec; 46(12):1839-41. PubMed ID: 16263591
    [No Abstract]   [Full Text] [Related]  

  • 64. Frontline therapy of severe aplastic anaemia with fludarabine, cyclophosphamide and ciclosporin.
    Liu Q; Zhao X; Xu N; Huang P; Li S; Zhang F; Wang J
    Br J Haematol; 2015 Nov; 171(3):427-30. PubMed ID: 25824311
    [No Abstract]   [Full Text] [Related]  

  • 65. Symptomatic BK virus reactivation following fludarabine, cyclophosphamide and rituximab chemotherapy for chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Appleby N; Dillon A; Arrigan M; Fennell J; Crowley B; Hayden PJ; Enright H
    Leuk Lymphoma; 2014 May; 55(5):1181-3. PubMed ID: 23987823
    [No Abstract]   [Full Text] [Related]  

  • 66. Characteristics of chronic lymphocytic leukemia patients achieving 5+ years of remission after FC-based first-line treatment: Retrospective observations from the FILO group.
    Guillermin Y; Herbaux C; Subtil F; Aurran-Schleinitz T; Cymbalista F; Letestu R; Leprêtre S; Vaudaux S; Laribi K; Leblond V; Defoi Y; Benchikh R; Salles G; Godmer P; Jardel H; Vallais F; Feugier P; Orsini F; Pegourié B; Lévy V; Michallet AS
    Am J Hematol; 2018 Jan; 93(1):E24-E27. PubMed ID: 29055105
    [No Abstract]   [Full Text] [Related]  

  • 67. [Long-term results of treatment of chronic B-cell lymphoid leukocytes in persons who participated in the elimination of the effects of the nuclear accident at the Chernobyl nuclear station].
    Klymenko VI; Bazyka DA; Polishchuk OM; Kriachok IA; Martina ZV; Kadnikova TV; Klymenko SV
    Lik Sprava; 2003; (1):18-20. PubMed ID: 12712601
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Rapid Multifocal Neurologic Decline in an Immunocompromised Patient.
    Kromm JA; Power C; Blevins G; Larratt L; van Landeghem FK; Rempel J
    JAMA Neurol; 2016 Feb; 73(2):226-31. PubMed ID: 26658958
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The chronic lymphocytic leukaemia market.
    Esencay M; Hamad B
    Nat Rev Drug Discov; 2015 Jun; 14(6):381-2. PubMed ID: 25976389
    [No Abstract]   [Full Text] [Related]  

  • 70. Acquired hemophilia in chronic lymphocytic leukemia.
    Mahipal A; Bilgrami S
    Leuk Lymphoma; 2007 May; 48(5):1026-8. PubMed ID: 17487748
    [No Abstract]   [Full Text] [Related]  

  • 71. Evolving Frontline Treatment in Chronic Lymphocytic Leukemia.
    Coutre SE
    Clin Adv Hematol Oncol; 2016 May; 14(5 Suppl 8):5-6. PubMed ID: 27168203
    [No Abstract]   [Full Text] [Related]  

  • 72. Massive swelling of the cervical region: an uncommon manifestation of B cell chronic lymphocytic leukemia.
    Becker ST; Wiltfang J; Klapper W; Repp R; Sinis N; Warnke PH
    Oral Maxillofac Surg; 2008 Dec; 12(4):205-8. PubMed ID: 18688662
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Chronic lymphocytic leukemia: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    ; Hallek M
    Ann Oncol; 2007 Apr; 18 Suppl 2():ii49-50. PubMed ID: 17491044
    [No Abstract]   [Full Text] [Related]  

  • 74. How I Manage Chronic Lymphocytic Leukemia in 2014.
    Alwbari A; Makhoul I
    J Ark Med Soc; 2016 Feb; 112(10):187-8. PubMed ID: 26939472
    [No Abstract]   [Full Text] [Related]  

  • 75. Seropositive arthritis in chronic lymphocytic leukemia: a remark on B cell-mediated autoimmunity.
    Onal IK; Ozçakar L; Dizdar O; Büyükaşik Y; Dündar S
    Rheumatol Int; 2005 Sep; 25(7):569-70. PubMed ID: 15761727
    [No Abstract]   [Full Text] [Related]  

  • 76. Myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: analysis of persistent and new-onset cytopenia.
    Gozzetti A; Defina M; Fabbri A
    Cancer; 2014 Feb; 120(3):451-2. PubMed ID: 24151174
    [No Abstract]   [Full Text] [Related]  

  • 77. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of chronic lymphocytic leukemia.
    Hallek M; Stahel RA; Greil R;
    Ann Oncol; 2005; 16 Suppl 1():i50-1. PubMed ID: 15888753
    [No Abstract]   [Full Text] [Related]  

  • 78. Analysis of criteria for treatment initiation in patients with progressive chronic lymphocytic leukemia.
    Mozas P; Rivas-Delgado A; Baumann T; Villamor N; Ortiz-Maldonado V; Aymerich M; Costa D; Navarro A; Giné E; López-Guillermo A; Montserrat E; Delgado J
    Blood Cancer J; 2018 Jan; 8(1):10. PubMed ID: 29339727
    [No Abstract]   [Full Text] [Related]  

  • 79. Transient absence of hepatic uptake on gallium-67 scintigraphy following fludarabine therapy.
    Huynh T; Mansberg R; Hsiao E; Coyle L; Roach P
    Clin Nucl Med; 2004 Apr; 29(4):275-6. PubMed ID: 15096981
    [No Abstract]   [Full Text] [Related]  

  • 80. The evolving role of time-limited targeted therapy in chronic lymphocytic leukemia.
    Molica S
    Expert Rev Anticancer Ther; 2020 Dec; 20(12):1015-1019. PubMed ID: 32985307
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.